Skip to main content

Allegro MicroSystems Appoints Brian White to its Board of Directors

MANCHESTER, N.H., June 18, 2026 (GLOBE NEWSWIRE) — Allegro MicroSystems, Inc. (Nasdaq: ALGM) today announced the appointment of Brian C. White to Allegro’s Board of Directors (“Board”) as an independent director. Mr. White’s appointment was effective on June 17, 2026. Mr. White is an accomplished executive and board director with over 30 years of leadership experience in the semiconductor and high-technology industries. He brings extensive expertise in financial strategy, public-company governance, and corporate development, having served as Chief Financial Officer for several publicly traded semiconductor companies, including Ambarella, Inc., Maxim Integrated Products, Inc., and Integrated Device Technology, Inc. “Brian’s public-company CFO perspective, semiconductor industry experience and governance background make him a strong...

Continue reading

Enphase Energy Begins Shipments of GaN-Based 548 VA IQ9S Commercial Microinverters in the United States

FREMONT, Calif., June 18, 2026 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company, today announced that it began production shipments of its IQ9S-3P™ Commercial Microinverter, the company’s most powerful microinverter currently available across the United States. Built with advanced gallium nitride (GaN) technology, the IQ9S-3P Commercial Microinverter supports high-wattage solar panels up to 770 W and connects directly to three-phase 480Y/277 V (wye) grid configurations without requiring external transformers. Safe harbor orders for IQ9S-3P Commercial Microinverters remain open and should be placed before July 4, 2026, to help customers secure equipment ahead of upcoming federal tax credit deadlines. Safe harbor orders placed before the deadline are expected to ship soon after,...

Continue reading

Hollister Teams Up with Target for Its First-Ever Home & Dorm Collaboration

The multi-season partnership, which includes apparel and bedding, marks Hollister’s debut in home décor and the next extension of the brand as students prep for college and back to schoolHollister x TargetHollister x TargetHollister x TargetHollister x TargetHollister x TargetHollister x TargetHollister x TargetHollister x TargetNEW ALBANY, Ohio, June 18, 2026 (GLOBE NEWSWIRE) — Hollister Co., a division of Abercrombie & Fitch Co. (NYSE: ANF), is launching The Hollister Collection at Target, marking the brand’s first move into the home and décor category. Available for purchase beginning June 28 on hollisterco.com, Target.com, in most Target stores and in select Hollister stores, the first drop of a multi-season partnership includes nearly 60 items across men’s and women’s apparel...

Continue reading

Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million

Proceeds from transaction to support advancement of Denali’s broad TransportVehicle™-enabled clinical portfolio for lysosomal storage disorders and neurodegenerative diseases Denali was awarded Priority Review Voucher following FDA approval of AVLAYAH™, the first FDA-approved biologic specifically designed to cross blood-brain barrierSOUTH SAN FRANCISCO, Calif., June 18, 2026 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (Nasdaq: DNLI) today announced it has entered into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of $195 million. The U.S. Food and Drug Administration (FDA) awarded the PRV to Denali following accelerated approval of the enzyme replacement therapy AVLAYAH™ (tividenofusp alfa-eknm) for the treatment of Hunter syndrome (mucopolysaccharidosis...

Continue reading

Premier Air Charter Discusses FAA Approval, Growth Strategy, and Market Trends in Follow-Up Interview

OTCID:PREM management recently participated in a follow-up interview to discuss the Company’s newly announced Federal Aviation Administration (FAA) approval to operate charter flights with 10 or more passengers and much more!CARLSBAD, Calif., June 18, 2026 (GLOBE NEWSWIRE) — Premier Air Charter Holdings Inc. (OTCID: PREM) (“Premier” or the “Company”), an emerging growth company in the private aviation sector, today announced that management recently participated in a follow-up interview to discuss the Company’s newly announced Federal Aviation Administration (FAA) approval to operate charter flights with 10 or more passengers, as well as its broader growth strategy and industry outlook. During the interview, Premier leadership highlighted the significance of the FAA approval as a key milestone that expands the...

Continue reading

BIO-key’s Fireside Chat at Maxim Group Defense Tech Conf. to Webcast Thur. June 25 at 4pm ET

HOLMDEL, N.J., June 18, 2026 (GLOBE NEWSWIRE) — BIO-key® International, Inc. (OTC Markets: BKYI), a provider of biometric authentication technologies used by leading military and defense ministries, announced that its CEO Michael DePasquale will participate in a webcast fireside chat at Maxim Group’s Defense Tech Virtual Conference, Thursday, June 25, 2026 at 4:00 pm ET (Track 2). The conversation will be led by Maxim Group Equity Analyst Jack Vander Aarde, including Q&A. Growing global tensions along with increasing incidents of military action are exposing a range of challenges to traditional strategies. In this virtual conference, Maxim Group Research Analysts sit down with company leaders racing to close the gaps and bring new capabilities to market. The event brings executive management from companies driving innovation...

Continue reading

Clearmind Medicine Granted U.S. Patent for Binge Behavior Regulators

Vancouver, Canada, June 18, 2026 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, neuroplastogens-derived therapeutics to solve major under-treated health problems, today announced that it has been granted a U.S. Patent, No. 12,350,242, titled “BINGE BEHAVIOR REGULATORS”, by the United States Patent and Trademark Office (USPTO). The patent, which refers to Clearmind’s molecule MEAI (5-methoxy-2-aminoindane), covers innovative compositions and methods utilizing a pharmaceutically acceptable salt to regulate binge behaviors, including excessive drinking, eating, and gambling. Dr. Adi Zuloff-Shani, CEO of Clearmind Medicine, commented: “We are very pleased to secure this...

Continue reading

Breckenridge Distillery Releases Limited Single Barrel Bourbon Collection

The Award-Winning Colorado Craft Distillery Releases Twelve Hand-Selected, Unblended Single Barrels — Breckenridge Bourbon in Its Most Honest FormBRECKENRIDGE, Colo., June 18, 2026 (GLOBE NEWSWIRE) — Breckenridge Distillery, one of the most-awarded craft distilleries in the U.S., and a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), today announced the limited release of its Breckenridge Distillery Single Barrel Bourbon Collection. These single barrel releases are an invitation to experience Breckenridge Bourbon in its most honest form; unblended, thoughtfully proofed, and defined by the barrel itself. Each barrel was hand-selected for its ability to stand entirely on its own, showcasing flavors that are complete, balanced, and compelling. All twelve expressions are aged a minimum of five years, developing depth...

Continue reading

Dragonfly Energy Strengthens IP Portfolio for Solid-State Battery Manufacturing with U.S. Patent Allowance

Patent milestone supports continued progress toward scalable production of next-generation lithium battery cells RENO, Nev., June 18, 2026 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage and maker of Battle Born Batteries®, today announced it has received a notice of allowance from the United States Patent and Trademark Office for its patent application titled “Powderized Solid-State Electrolyte and Electroactive Materials.” The allowed patent application is directed toward manufacturing processes that support Dragonfly Energy’s solid-state battery development efforts. The technology further strengthens the Company’s U.S. intellectual property position in advanced battery cell manufacturing. “This U.S. patent allowance milestone is an...

Continue reading

Prosper Gold Announces Agreement to Sell Golden Sidewalk Project

VANCOUVER, British Columbia, June 18, 2026 (GLOBE NEWSWIRE) — Prosper Gold Corp. (“Prosper Gold” or the “Company”) (TSXV:PGX) announces that the Company has entered into a definitive purchase agreement (the “Purchase Agreement”) with Kenorland Exploration Ltd. (“Kenorland” or the “Purchaser”), pursuant to which the Company has agreed to sell to Kenorland its 100% interest in the Golden Sidewalk and Skinner properties (the “Properties”) located approximately 60 km east of Red Lake, Ontario (the “Transaction”). Kenorland is at arm’s length to the Company. As consideration for the sale of the Properties, Kenorland will pay C$1,000,000 in cash (the “Consideration”) to the Company on the closing date of the Transaction (“Closing”). Transaction Details The Transaction is subject to the approval of two thirds of the votes cast in person...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.